OncoImmunology
短名 | Oncoimmunology |
Journal Impact | 6.52 |
国际分区 | ONCOLOGY(Q1) |
期刊索引 | SCI Q1中科院 2 区 |
ISSN | 2162-4011, 2162-402X |
h-index | 114 |
国内分区 | 医学(2区)医学免疫学(2区)医学肿瘤学(2区) |
肿瘤免疫学处理癌症的自然或治疗诱导的识别,以及肿瘤发生、炎症和免疫监视之间复杂的相互作用。我们现在创建了一个新的、备受瞩目的期刊 ONCOIMMUNOLOGY,专门研究肿瘤免疫学。最近的进展使得抗癌免疫疗法的首次临床证明(和 FDA 批准)成为可能。也有越来越多的怀疑——出乎意料地——许多目前使用的化学治疗剂的功效取决于免疫效应器的积极贡献。用一个激烈的比喻来说,应用成功的化疗(或放疗)方案的肿瘤学家利用免疫系统识别肿瘤特异性或肿瘤相关抗原和控制癌症(干)细胞生长的能力,却没有意识到无形的帮助之手。因此,免疫生物标志物对于确定癌症的预后和预测化学疗法的疗效变得越来越重要。还有一个强有力的理由支持将传统的抗癌疗法与免疫疗法相结合。肿瘤免疫学将接受高-在肿瘤免疫学的基础、转化和临床领域提交简介。欢迎提交涉及实体或血液癌症、炎症、先天性和获得性免疫反应的提交。
期刊主页投稿网址涉及主题 | 医学生物遗传学内科学免疫学癌症研究免疫系统癌症化学生物化学免疫疗法抗原病理基因体外肿瘤科受体细胞生物学细胞毒性T细胞 |
出版信息 | 出版商: Landes Bioscience,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2012,原创研究文献占比: 94.25%,自引率:3.10%, Gold OA占比: 100.00% |
平均审稿周期 | 网友分享经验:24 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy
2024-9-12
CD4 <sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
2024-8-27
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma
2024-8-26
Metabolic regulation of the mitochondrial immune checkpoint
2024-8-26
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade
2024-8-22
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products
2024-8-22
Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, <i>SOX2</i> , and <i>CD44</i> through NFκB-signaling
2024-8-21
<i>FCGR3A</i> F158V alleles frequency differs in multiple myeloma patients from healthy population
2024-8-18
Correction
2024-8-11
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
2024-8-10
Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade glioma
2024-8-9
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphoma
2024-8-5
Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
2024-7-27
Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells
2024-7-27
CXCR1/2 antagonism inhibits neutrophil function and not recruitment in cancer
2024-7-26
S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs
2024-7-24
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
2024-7-18
Human NK cells and cancer
2024-7-16
Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment
2024-7-10
SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion
2024-7-9
Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism
2024-7-9
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes
2024-7-8
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodes
2024-7-4
Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden
2024-7-3
<i>Faecalibacterium prausnitzii</i> strain EXL01 boosts efficacy of immune checkpoint inhibitors
2024-7-1
Candidate tumor-specific CD8 <sup>+</sup> T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis
2024-6-28
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
2024-6-28
Identification of RNA-binding protein hnRNP C targeting the 3’UTR of the TAP-associated glycoprotein tapasin in melanoma
2024-6-27
CD161 <sup>+</sup> CD127 <sup>+</sup> CD8 <sup>+</sup> T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
2024-6-27
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity
2024-6-27
Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients
2024-6-26
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)
2024-6-24
ADA/CD26 axis increases intra-tumor PD-1 <sup>+</sup> CD28 <sup>+</sup> CD8 <sup>+</sup> T-cell fitness and affects NSCLC prognosis and response to ICB
2024-6-21
Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses
2024-6-21
Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
2024-6-20
ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors
2024-6-14
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescent
2024-6-14
Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34
2024-6-11
Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer
2024-6-10
HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer
2024-6-5
β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers
2024-6-4
CD20 expression regulates CD37 levels in B-cell lymphoma – implications for immunotherapies
2024-6-4
Immunogenic oncolysis by tigilanol tiglate
2024-5-27
Clinically relevant GABARAP deficiency abrogates bortezomib-induced immunogenic cell death in multiple myeloma
2024-5-27
CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival
2024-5-24
Peripheral CX3CR1 <sup>+</sup> T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer
2024-5-22
HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis
2024-5-20
CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage
2024-5-10
Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors
2024-5-10
Distinct autoantibody profiles across checkpoint inhibitor types and toxicities
2024-5-9
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远